Today, the European Commission initiated its first investigation under its International Procurement Instrument (IPI), in response to measures and practices in the Chinese procurement market for medical devices which it says "discriminate unfairly against European companies and products."

You don't have access to this post on China Trade Monitor at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.

This post is for subscribers only

Subscribe now